Harvard Apparatus Regenerative Technology HRGN
OTC HRGN
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Harvard Apparatus Regenerative Technology (HRGN) Share-based Compensation (2012 - 2026)

Updated

Harvard Apparatus Regenerative Technology's Share-based Compensation was $223,000 in Q2 2026, down 58.5% from $537,000 a year earlier and down 64.7% from the prior quarter.

Analysis

Harvard Apparatus Regenerative Technology (HRGN) Share-based Compensation (2012 - 2026) Analysis & Trends

On a trailing twelve-month basis, Harvard Apparatus Regenerative Technology's Share-based Compensation was $1.84 million through Jun 30, 2026, down 19.6% year-over-year; for FY2025, it was $2.01 million, down 16.3% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 11.9% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $2.4 million in FY2024 (-30.6%), $3.46 million in FY2023 (+235.7%), $1.03 million in FY2022 (+5.2%) and $980,000 in FY2021 (-14.3%).
  • The Q2 2026 figure marks the lowest quarterly Share-based Compensation since Q3 2021.
  • Compared with a year earlier, Share-based Compensation was higher in three of the last eight quarters, with an average decline of 8.5%.
  • The best year-over-year quarter for Share-based Compensation over five years was Q1 2023 (growth of 683.0%); the worst was Q1 2024 (a decline of 69.6%).
  • Per Business Quant data, HRGN's Share-based Compensation in the three quarters before Q2 2026 was $632,000 (Q1 2026), $493,000 (Q4 2025) and $495,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 458.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 166.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 231.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 249.00 Mn
10 Harvard Apparatus Regenerative Technology 38.50 Mn 35.01 Mn 23,000.00 223,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 223,000.00
Mar 31, 2026 632,000.00
Dec 31, 2025 493,000.00
Sep 30, 2025 495,000.00
Jun 30, 2025 537,000.00
Mar 31, 2025 485,000.00
Dec 31, 2024 708,000.00
Sep 30, 2024 562,000.00
Jun 30, 2024 572,000.00
Mar 31, 2024 560,000.00
Dec 31, 2023 607,000.00
Sep 30, 2023 535,000.00
Jun 30, 2023 479,000.00
Mar 31, 2023 1.84 Mn
Dec 31, 2022 275,000.00
Sep 30, 2022 244,000.00
Jun 30, 2022 277,000.00
Mar 31, 2022 235,000.00
Dec 31, 2021 559,000.00
Sep 30, 2021 160,000.00
API Access

Harvard Apparatus Regenerative Technology Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=HRGN&period=max&api_key=YOUR_API_KEY